Back to VANGUARD GROUP INC VANGUARD GROUP INC

NBIXNBIX
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in NEUROCRINE BIOSCIENCES INC

VANGUARD GROUP INC holds 9.7M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $1.4B as of 2025-Q4. The position was decreased (-0.1% shares). NBIX represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$1.4B

Current Shares

9.7M

Total Value Change

+$223.9M

Total Shares Change

-296,659

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
9.7M
-0.1%
$1.4B0.0%$140.95
0
2025-Q3
Decreased
9.7M
-1.0%
$1.4B0.0%$140.27
0
2025-Q2
Decreased
9.8M
-1.4%
$1.2B0.0%$125.42
0
2025-Q1
Decreased
9.9M
-1.8%
$1.1B0.0%$113.16
0
2024-Q4
Increased
10.1M
+1.2%
$1.4B0.0%$137.06
32
2024-Q3
New
10M
-
$1.2B0.0%$115.06
44

Other major holders of NBIX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used